Works matching IS 10837159 AND DT 2018 AND VI 23 AND IP 12

Results: 33
    1
    2

    In Reply.

    Published in:
    2018
    By:
    • Dang, Chau T.;
    • Singh, Jasmeet C.;
    • Steingart, Richard M.;
    • Yu, Anthony F.
    Publication type:
    Letter to the Editor
    3
    4

    In Reply.

    Published in:
    2018
    By:
    • Durani, Urshila;
    • Go, Ronald S.
    Publication type:
    Letter to the Editor
    5
    6
    7
    8

    Modulation of Premetastatic Niche by the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Localized High‐Risk Prostate Cancer Followed by Radical Prostatectomy: A Phase II Randomized Trial.

    Published in:
    Oncologist, 2018, v. 23, n. 12, p. 1413, doi. 10.1634/theoncologist.2018-0652
    By:
    • Maughan, Benjamin L.;
    • Pal, Sumanta K.;
    • Gill, David;
    • Boucher, Kenneth;
    • Martin, Christopher;
    • Salgia, Meghan;
    • Nussenzveig, Roberto;
    • Liu, Ting;
    • Hawks, Josiah L.;
    • Batten, Julia;
    • Nachaegari, Gayatri;
    • Stephenson, Robert;
    • Lowrance, William;
    • Jones, Jeremy;
    • Dechet, Christopher;
    • Agarwal, Neeraj
    Publication type:
    Article
    9
    10
    11

    Durable Response to Nivolumab in a Pediatric Patient with Refractory Glioblastoma and Constitutional Biallelic Mismatch Repair Deficiency.

    Published in:
    Oncologist, 2018, v. 23, n. 12, p. 1401, doi. 10.1634/theoncologist.2018-0163
    By:
    • AlHarbi, Musa;
    • Ali Mobark, Nahla;
    • AlMubarak, Latifa;
    • Aljelaify, Rasha;
    • AlSaeed, Mariam;
    • Almutairi, Amal;
    • Alqubaishi, Fatmah;
    • Hussain, M. Emarat;
    • Balbaid, Ali Abdullah O.;
    • Said Marie, Amal;
    • AlSubaie, Lamia;
    • AlShieban, Saeed;
    • alTassan, Nada;
    • Ramkissoon, Shakti H.;
    • Abedalthagafi, Malak
    Publication type:
    Article
    12
    13
    14

    Randomized, Open‐Label Phase II Study Comparing Capecitabine‐Cisplatin Every 3 Weeks with S‐1‐Cisplatin Every 5 Weeks in Chemotherapy‐Naïve Patients with HER2‐Negative Advanced Gastric Cancer: OGSG1105, HERBIS‐4A Trial

    Published in:
    Oncologist, 2018, v. 23, n. 12, p. 1411, doi. 10.1634/theoncologist.2018-0175
    By:
    • Kawakami, Hisato;
    • Takeno, Atsushi;
    • Endo, Shunji;
    • Makari, Yoichi;
    • Kawada, Junji;
    • Taniguchi, Hirokazu;
    • Tamura, Shigeyuki;
    • Sugimoto, Naotoshi;
    • Kimura, Yutaka;
    • Tamura, Takao;
    • Fujitani, Kazumasa;
    • Sakai, Daisuke;
    • Shimokawa, Toshio;
    • Kurokawa, Yukinori;
    • Satoh, Taroh
    Publication type:
    Article
    15
    16

    A Phase I Dose‐Escalation Study of Linsitinib (OSI‐906), a Small‐Molecule Dual Insulin‐Like Growth Factor‐1 Receptor/Insulin Receptor Kinase Inhibitor, in Combination with Irinotecan in Patients with Advanced Cancer.

    Published in:
    Oncologist, 2018, v. 23, n. 12, p. 1409, doi. 10.1634/theoncologist.2018-0315
    By:
    • Davis, S. Lindsey;
    • Eckhardt, S. Gail;
    • Diamond, Jennifer R.;
    • Messersmith, Wells A.;
    • Dasari, Arvind;
    • Weekes, Colin D.;
    • Lieu, Christopher H.;
    • Kane, Madeline;
    • Choon Tan, Aik;
    • Pitts, Todd M.;
    • Leong, Stephen
    Publication type:
    Article
    17
    18
    19
    20
    21
    22

    Prognostic Nomogram Based on Histological Characteristics of Fibrotic Tumor Stroma in Patients Who Underwent Curative Resection for Intrahepatic Cholangiocarcinoma.

    Published in:
    Oncologist, 2018, v. 23, n. 12, p. 1482, doi. 10.1634/theoncologist.2017-0439
    By:
    • Jing, Chu‐Yu;
    • Fu, Yi‐Peng;
    • Huang, Jin‐Long;
    • Zhang, Mei‐Xia;
    • Yi, Yong;
    • Gan, Wei;
    • Xu, Xin;
    • Shen, Hu‐Jia;
    • Lin, Jia‐Jia;
    • Zheng, Su‐Su;
    • Zhang, Juan;
    • Zhou, Jian;
    • Fan, Jia;
    • Ren, Zheng‐Gang;
    • Qiu, Shuang‐Jian;
    • Zhang, Bo‐Heng
    Publication type:
    Article
    23

    Machine Learning for Better Prognostic Stratification and Driver Gene Identification Using Somatic Copy Number Variations in Anaplastic Oligodendroglioma.

    Published in:
    Oncologist, 2018, v. 23, n. 12, p. 1500, doi. 10.1634/theoncologist.2017-0495
    By:
    • Rosenberg, Shai;
    • Ducray, Francois;
    • Alentorn, Agusti;
    • Dehais, Caroline;
    • Elarouci, Nabila;
    • Kamoun, Aurelie;
    • Marie, Yannick;
    • Tanguy, Marie‐Laure;
    • De Reynies, Aurélien;
    • Mokhtari, Karima;
    • Figarella‐Branger, Dominique;
    • Delattre, Jean‐Yves;
    • Idbaih, Ahmed;
    • Desenclos, C.;
    • Sevestre, H.;
    • Menei, P.;
    • Rousseau, A.;
    • Cruel, T.;
    • Lopez, S.;
    • Mihai, M‐I
    Publication type:
    Article
    24

    In the Patient's Shoes.

    Published in:
    Oncologist, 2018, v. 23, n. 12, p. 1546, doi. 10.1634/theoncologist.2017-0525
    By:
    • Coradazzi, Ana Lucia
    Publication type:
    Article
    25

    Cluster Analysis Demonstrates the Need to Individualize Care for Cancer Survivors.

    Published in:
    Oncologist, 2018, v. 23, n. 12, p. 1474, doi. 10.1634/theoncologist.2017-0558
    By:
    • de Rooij, Belle H.;
    • Park, Elyse R.;
    • Perez, Giselle K.;
    • Rabin, Julia;
    • Quain, Katharine M.;
    • Dizon, Don S.;
    • Post, Kathryn E.;
    • Chinn, Garrett M.;
    • McDonough, Allison L.;
    • Jimenez, Rachel B.;
    • van de Poll‐Franse, Lonneke V.;
    • Peppercorn, Jeffrey
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32

    Volume 23 Acknowledgments.

    Published in:
    Oncologist, 2018, v. 23, n. 12, p. e179, doi. 10.1634/theoncologist.2018-r000
    Publication type:
    Article
    33

    Volume 23 Author Index.

    Published in:
    Oncologist, 2018, v. 23, n. 12, p. e167, doi. 10.1634/theoncologist.2018-a000
    Publication type:
    Article